SCA
IDYA icon

Snowden Capital Advisors’s IDEAYA Biosciences IDYA Stock Holding History

Snowden Capital Advisors’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$641K Buy
19,231
+1,671
+10% +$56.1K 0.02% 689
2025
Q4 		$607K Sell
17,560
-166
-0.9% -$5.29K 0.02% 711
2025
Q3 		$482K Buy
17,726
+4,095
+30% +$99K 0.01% 795
2025
Q2 		$287K Buy
13,631
+2,328
+21% +$44.7K 0.01% 1027
2025
Q1 		$185K Sell
11,303
-336
-3% -$7.16K 0.01% 1166
2024
Q4 		$299K Sell
11,639
-77
-0.7% -$2.18K 0.01% 987
2024
Q3 		$371K Buy
11,716
+442
+4% +$16.8K 0.01% 902
2024
Q2 		$396K Buy
+11,274
New +$446K 0.01% 860

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LGM
Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return